ABSTRACT
Regulatory inspections are conducted before a new drug or device can be approved, to verify production method and technology changes, and periodically verify every 2 or 3 years that GxP practices are being maintained. Inspections are used to determine if processes are adequately validated with documentary evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality characteristics.1
